Pre_GI: SWBIT SVG BLASTN

Query: NC_009725:496443 Bacillus amyloliquefaciens FZB42, complete genome

Lineage: Bacillus amyloliquefaciens; Bacillus; Bacillaceae; Bacillales; Firmicutes; Bacteria

General Information: Bacillus amyloliquefaciens strain FZB42 was isolated from soil, and is a member of a group of free-living soil bacteria known to promote plant growth and suppress plant pathogens. Plant growth promoting bacterium. Bacillus amyloliquefaciens is a member of a group of free-living soil bacteria known to promote plant growth and suppress plant pathogens. Bacillus amyloliquefaciens is able to degrade myo-inositol hexakisphosphate (phytate), making phosphorus more available to plants. This organism also produces antifungal and antibacterial substances, such as bacillomycin D, surfactin, and bacillaene, which protect the plant from pathogenic organisms. In addition, proteases and amylases produced by Bacillus amyloliquefaciens are used in industrial applications.

No Graph yet!

Subject: NC_005303:553500 Onion yellows phytoplasma OY-M, complete genome

Lineage: Onion yellows phytoplasma; Phytoplasma; Acholeplasmataceae; Acholeplasmatales; Tenericutes; Bacteria

General Information: This strain (OY-M) is derived from a wild-type disease-causing strain (OY-W; onions yellow disease) which was isolated in Saga Prefecture, Japan, in 1982, and shows mild symptoms and does not cause stunting nor phloem hyperplasia (excessive increase in number of cells). Plant pathogenic bacterium. Phytoplasmas inhabit phloem (food-conducting vascular tissue) sieve elements of plants where they cause a variety of diseases. There is great interest in sequencing these organisms since they are currently unculturable and examination of the genome may lead to methods to deal with the diseases they cause including the development of antimicrobial agents. There is great interest in sequencing these organisms since they are currently unculturable and examination of the genome may lead to methods to deal with the diseases they cause including the development of antimicrobial agents.